Palacaparib + Datopotamab Deruxtecan

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Palacaparib + Datopotamab Deruxtecan
Treatment and conditionWhere it standsTrials
Palacaparib + Datopotamab Deruxtecan for astrocytomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Palacaparib + Datopotamab Deruxtecan for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Palacaparib + Datopotamab Deruxtecan for prostatic neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1